Chemicals & Advanced Materials Global On demand · 24-48h

Global Ursolic Acid Market Strategic Research Report

Global Ursolic Acid Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Ursolic Acid Market
$8.062025
3.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Others

By Application: Pharmaceutical, Cosmetic, Food and Health Care Products

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Sami-Sabinsa, Changsha Staherb Natural Ingredients, Run Shaanxi Days of Bio-tech, Shaanxi Huike Botanical Development, Changsha Luyuan Bio-Tech, Xuancheng Baicao Pharmaceutical, Changsha E.K HERB, Shaanxi Jintai Biological Engineering, Hunan NutraMax, Xi’an TonKing, MicroHerb, Geneham Pharmaceutical, Acetar Bio-Tech, Shaanxi Hopeland Chem-Tech, Xi'an Tianben Bio-Engineering, AiKan Biological, Ningshan Guosheng Biological Technology, Yongzhou Huamao Biotechnology, Baoji Guokang Bio-Technology, Hunan Warrant Pharmaceutical, Shaaxi Haiqiang Phytochemical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 158 pages
Market size 2025
$8.06
Million USD
Forecast CAGR
3.9%
2025-2032
Forecast 2032
$10.5
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Ursolic Acid market size is predicted to grow from US$ 8.06 million in 2025 to US$ 10.51 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032.

Ursolic acid is a lipophilic pentacyclic triterpenoid. It is a biologically active compound found in many plants (a phytochemical). It is widely used in pharmaceutical industry, cosmetic industry and food&health care products industry, because of its anti-inflammatory, antifungal, antitumor, antiulcer and antiviral properties.

The whole ursolic acid industry is relatively scattered as there are many medium and small size companies engaged in. China is the largest producer of the product.

Market Drivers:

Growing Demand for Natural Ingredients: Ursolic acid, derived primarily from apple peel and various herbs, is gaining popularity in the cosmetic and pharmaceutical industries due to its natural origin. As consumers increasingly seek natural, plant-based products, the demand for ursolic acid has grown, particularly in skincare formulations and dietary supplements.

Anti-Inflammatory and Antioxidant Properties: Ursolic acid is recognized for its anti-inflammatory, antioxidant, and anti-cancer properties. These health benefits have driven its application in various therapeutic areas, particularly in managing chronic diseases like diabetes, obesity, and heart disease. This has increased its demand in the nutraceutical market.

Increasing Awareness of Healthy Lifestyles:As global awareness about healthy lifestyles and preventive healthcare rises, consumers are turning to natural products that can help improve their overall health. Ursolic acid, with its broad spectrum of health benefits, has become a popular ingredient in weight management, anti-aging, and immunity-boosting products.

Expansion of the Cosmetic Industry: The cosmetic industry has been increasingly adopting ursolic acid for its skin-enhancing properties. It is used in formulations for anti-aging, skin firming, and moisturizing products. This trend is contributing to the growth of the ursolic acid market.

Market Challenges:

Limited Availability of Raw Materials: Ursolic acid is primarily sourced from natural herbs like rosemary, thyme, and apple peel, which limits the consistency and volume of supply. Fluctuations in the availability of these raw materials can impact production rates and pricing.

Competition from Synthetic Alternatives: Synthetic substitutes and other natural compounds with similar health benefits may pose a threat to the growth of the ursolic acid market. These alternatives may be cheaper and more readily available, which could make it difficult for ursolic acid to compete in certain sectors.

This report presents a comprehensive overview of the global Ursolic Acid market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 25% Ursolic Acid
  • 50% Ursolic Acid
  • 90% Ursolic Acid
  • 98% Ursolic Acid
  • Others

Segment by Application

  • Pharmaceutical
  • Cosmetic
  • Food and Health Care Products

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ursolic Acid market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical, Cosmetic, Food and Health Care Products evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Ursolic Acid Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$8.06
2025
Forecast
$10.5
2032
CAGR
3.9%
2025–2032
영역들
5
global
Key companies
Sami-SabinsaChangsha Staherb Natural IngredientsRun Shaanxi Days of Bio-techShaanxi Huike Botanical DevelopmentChangsha Luyuan Bio-TechXuancheng Baicao PharmaceuticalChangsha E.K HERBShaanxi Jintai Biological Engineering
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
25% Ursolic Acid50% Ursolic Acid90% Ursolic Acid98% Ursolic AcidOthers
By Application
PharmaceuticalCosmeticFood and Health Care Products

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 25% Ursolic Acid
  • 3.1.3 50% Ursolic Acid
  • 3.1.4 90% Ursolic Acid
  • 3.1.5 98% Ursolic Acid
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical
  • 4.1.3 Cosmetic
  • 4.1.4 Food and Health Care Products
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Sami-Sabinsa
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Changsha Staherb Natural Ingredients
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Run Shaanxi Days of Bio-tech
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Shaanxi Huike Botanical Development
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Changsha Luyuan Bio-Tech
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Xuancheng Baicao Pharmaceutical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Changsha E.K HERB
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shaanxi Jintai Biological Engineering
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Hunan NutraMax
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Xi’an TonKing
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 MicroHerb
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Geneham Pharmaceutical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Acetar Bio-Tech
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shaanxi Hopeland Chem-Tech
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Xi'an Tianben Bio-Engineering
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 AiKan Biological
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Ningshan Guosheng Biological Technology
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Yongzhou Huamao Biotechnology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Baoji Guokang Bio-Technology
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Hunan Warrant Pharmaceutical
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Shaaxi Haiqiang Phytochemical
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Ursolic Acid market?
The global Ursolic Acid market is estimated at US$ 8.06 million in 2025 (base year) and is projected to reach US$ 10.51 million by 2032.
What is the forecast CAGR for the Ursolic Acid market?
The market is expected to grow at a CAGR of 3.9% from 2026 to 2032, expanding from US$ 8.06 million in 2025 to US$ 10.51 million in 2032, roughly 1.3 times its base-year value.
What is Ursolic Acid?
Ursolic acid is a lipophilic pentacyclic triterpenoid. It is a biologically active compound found in many plants (a phytochemical). It is widely used in pharmaceutical industry, cosmetic industry and food&health care products industry, because of its anti-inflammatory, antifungal, antitumor, antiulcer and antiviral properties.
How is the Ursolic Acid market segmented by type?
By type, the market is segmented into 25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid and Others.
What are the key applications of Ursolic Acid?
Key applications covered include Pharmaceutical, Cosmetic and Food and Health Care Products.
Which companies are profiled in the Ursolic Acid market report?
Key players profiled include Sami-Sabinsa, Changsha Staherb Natural Ingredients, Run Shaanxi Days of Bio-tech, Shaanxi Huike Botanical Development, Changsha Luyuan Bio-Tech, Xuancheng Baicao Pharmaceutical, Changsha E.K HERB and Shaanxi Jintai Biological Engineering, among 21 companies covered in total.
What geographies does the Ursolic Acid market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Ursolic Acid?
These health benefits have driven its application in various therapeutic areas, particularly in managing chronic diseases like diabetes, obesity, and heart disease.
Who should buy the Ursolic Acid market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical, Cosmetic and Food and Health Care Products, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Ursolic Acid market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.